The Food and Drug Administration warns that a recent study suggests the antidepressant Paxil may be associated with birth defects.

Paxil's manufacturer, GlaxoSmithKline, says it will include the results of the study in the drug's precaution list

The U.S. Food and Drug Administration is fast tracking a new drug named "arimoclomol", for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).

Pharmaceutical giant, CytRx, announces the initiation of a phase II clinical trial with orally-administered arimoclomol for ALS, and patient identification for this trial, which currently is underway at several clinical trial sites. Arimoclomol was granted orphan drug status designation by the FDA for the treatment of ALS in May 2005

The U.S. Food and Drug Administration is fast tracking a new drug named "arimoclomol", for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease).

Pharmaceutical giant, CytRx, announces the initiation of a phase II clinical trial with orally-administered arimoclomol for ALS, and patient identification for this trial, which currently is underway at several clinical trial sites. Arimoclomol was granted orphan drug status designation by the FDA for the treatment of ALS in May 2005

Dr. Andrew C. von Eschenbach, named the temporary head of the Food and Drug Administration, says the agency needs to focus on emerging discoveries on the mechanisms of disease that may lead to new treatments.

President Bush appointed von Eschenbach following the surprise resignation of Commissioner Lester Crawford Friday

Hector Duarte Jr. - All Headline News Staff Reporter

On Sunday, Montefiore Medical Center confirms Clarence began walking on his own after "Dateline NBC" showed images of the 3-year-old taking steps at Blythedale Children's Hospital in Valhalla